These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 34404526)
1. Thrombopoietin receptor agonists for marrow failure: A concise clinical review. Kapoor S; Champion G; Olnes MJ Best Pract Res Clin Haematol; 2021 Jun; 34(2):101274. PubMed ID: 34404526 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes. Townsley DM; Desmond R; Dunbar CE; Young NS Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288 [TBL] [Abstract][Full Text] [Related]
3. Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation. Fattizzo B; Levati G; Cassin R; Barcellini W Drugs; 2019 Aug; 79(12):1305-1319. PubMed ID: 31292909 [TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic choices in immune aplastic anemia. Scheinberg P F1000Res; 2020; 9():. PubMed ID: 32953089 [TBL] [Abstract][Full Text] [Related]
5. Upfront eltrombopag monotherapy induces stable hematologic remission in pediatric patients with nonsevere idiopathic aplastic anemia. Geng W; Kearney S; Nelson S Pediatr Blood Cancer; 2018 Oct; 65(10):e27290. PubMed ID: 29932285 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy in severe aplastic anemia. Patel BA; Townsley DM; Scheinberg P Semin Hematol; 2022 Jan; 59(1):21-29. PubMed ID: 35491055 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Treatment of Aplastic Anemia. Peslak SA; Olson T; Babushok DV Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887 [TBL] [Abstract][Full Text] [Related]
8. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296 [TBL] [Abstract][Full Text] [Related]
9. Persistent elevated bone marrow plasma levels of thrombopoietin in patients with aplastic anemia. Zhang J; Wu Q; Zheng Y Cytokine; 2016 Sep; 85():11-3. PubMed ID: 27269179 [TBL] [Abstract][Full Text] [Related]
10. [Hematopoietic recovery by ASXL1-mutated clones after immune suppressive therapy in a patient with severe aplastic anemia]. Shimizu Y; Nishikii H; Iitsuka T; Matsuoka R; Kurita N; Sakamoto T; Yokoyama Y; Kato T; Suehara Y; Hattori K; Maruyama Y; Nannya Y; Ogawa S; Sakata-Yanagimoto M; Chiba S; Obara N Rinsho Ketsueki; 2023; 64(1):49-53. PubMed ID: 36775307 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of thrombopoietin in bone marrow failure]. Shiozaki H; Nakamura-Ishizu A; Suda T Rinsho Ketsueki; 2020; 61(10):1449-1458. PubMed ID: 33162439 [TBL] [Abstract][Full Text] [Related]
12. Management of aplastic anemia after failure of frontline immunosuppression. Pierri F; Dufour C Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355 [No Abstract] [Full Text] [Related]
13. [Successful treatment of eltrombopag following immunosuppressive therapy in pediatric aplastic anemia]. Kubota I; Nagasawa S; Nakagawa M; Yamada A; Kinoshita M; Kamimura S; Shimonodan H; Moritake H Rinsho Ketsueki; 2023; 64(8):741-745. PubMed ID: 37673625 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes in adult patients with aplastic anemia: A single institution experience. Boddu P; Garcia-Manero G; Ravandi F; Borthakur G; Jabbour E; DiNardo C; Jain N; Daver N; Pemmaraju N; Anderlini P; Parmar S; Kc D; Akosile M; Pierce SA; Champlin R; Cortes J; Kantarjian H; Kadia T Am J Hematol; 2017 Dec; 92(12):1295-1302. PubMed ID: 28850699 [TBL] [Abstract][Full Text] [Related]
15. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy. Yamazaki H; Ohta K; Iida H; Imada K; Obara N; Tokumine Y; Tomiyama Y; Usuki K; Imajo K; Miyamura K; Sasaki O; Fanghong Z; Hattori T; Tajima T; Matsuda A; Nakao S Int J Hematol; 2019 Aug; 110(2):187-196. PubMed ID: 31183813 [TBL] [Abstract][Full Text] [Related]
16. Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia. Pan P; Chen C; Hong J; Gu Y Int Immunopharmacol; 2023 Apr; 117():110036. PubMed ID: 36940553 [TBL] [Abstract][Full Text] [Related]
17. Up-front Treatment With Romiplostim in Children With Acquired Bone Marrow Failure: A Single Institutional Pediatric Case Series. Al-Huniti A; Rathi N; Modi A; Bhagavathi S; Mitten R; Sharathkumar AA J Pediatr Hematol Oncol; 2021 Apr; 43(3):e431-e435. PubMed ID: 32341259 [TBL] [Abstract][Full Text] [Related]
18. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia. Marsh JCW; Risitano AM; Mufti GJ Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354 [TBL] [Abstract][Full Text] [Related]
19. Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution. Matsuda A; Imada K; Obara N; Iida H; Yamazaki H; Tomiyama Y; Miyamura K; Sasaki O; Maeda T; Ohta K; Usuki K; Tokumine Y; Imajo K; Okamoto Y; Murakami M; Nakao S Am J Clin Pathol; 2022 Nov; 158(5):604-615. PubMed ID: 36018052 [TBL] [Abstract][Full Text] [Related]
20. [Acquired aplastic anemia: recent advances in pathophysiology and treatment]. Yamazaki H Rinsho Ketsueki; 2018; 59(6):711-715. PubMed ID: 29973449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]